Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BBLG | Non-Employee Stock Option | Award | $0 | +30.7K | $0.00 | 30.7K | Sep 17, 2024 | Common Stock | 30.7K | $1.73 | Direct | F1 | |
holding | BBLG | Non-Employee Stock Option | 10.7K | Sep 17, 2024 | Common Stock | 10.7K | $5.12 | Direct | F2 | |||||
holding | BBLG | Non-Employee Stock Option | 154 | Sep 17, 2024 | Common Stock | 154 | $387.26 | Direct | F2 | |||||
holding | BBLG | Non-Employee Stock Option | 37 | Sep 17, 2024 | Common Stock | 37 | $844.80 | Direct | F2 | |||||
holding | BBLG | Non-Employee Stock Option | 13 | Sep 17, 2024 | Common Stock | 13 | $1,260.00 | Direct | F2 | |||||
holding | BBLG | Non-Employee Stock Option | 84 | Sep 17, 2024 | Common Stock | 84 | $1,260.00 | Direct | F2 |
Id | Content |
---|---|
F1 | This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company. |
F2 | This option is fully exercisable as of the date of this report. |